MBCL-22. EFFICACY OF DOUBLE-CONDITIONING REGIMEN COMPRISING THIOTEPA AND MELPHALAN FOR RELAPSED MEDULLOBLASTOMA – A SINGLE INSTITUTION EXPERIENCE

BACKGROUND: The prognosis of relapsed medulloblastoma was dismal. Recently, we published the promising outcome of metastatic medulloblastomas treated with a double-conditioning regimen comprising high-dose thiotepa and melphalan (HD-TM). Here, we report a single-center study of HD-TM for relapsed me...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuro Oncol
Hauptverfasser: Yamasaki, Kai, Tanimura, Kazuki, Okuhiro, Yuki, Hira, Kota, Nitani, Chika, Okada, Keiko, Fujisaki, Hiroyuki, Kunihiro, Noritsugu, Matsusaka, Yasuhiro, Sakamoto, Hiroaki, Hara, Junichi
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2020
Schlagworte:
Medulloblastoma (Clinical)
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715182/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.498
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge